January 2, 2019 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals’ Prior Approval ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
December 17, 2018 — Among otherwise healthy people, a daily dose of aspirin does not save lives and causes additional ...
December 11, 2018 — Mylan Pharmaceuticals is expanding its consumer-level voluntary nationwide recall to include all ...
December 7, 2018 — New data from the Phase 3 CASSINI study showed a 60 percent reduction of venous thromboembolism (VTE ...
November 30, 2018 — Healthcare technology company Livongo recently announced the launch of its Applied Health Signals ...
November 16, 2018 — A research team led by scientists and doctors in Leicester and the Netherlands has shown that a ...
November 15, 2018 — AstraZeneca announced positive full results from the DECLARE-TIMI 58 cardiovascular (CV) outcomes ...
Deepak L. Bhatt, M.D., executive director of the interventional cardiovascular program, Brigham and Women’s Hospital ...
November 13, 2018 — A study in the current edition of the New England Journal of Medicine1 shows that a particular ...
November 6, 2018 – Initial results from the real-world EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) ...
November 1, 2018 — A vaccine may one day be able to replace oral blood thinners to reduce the risk of secondary strokes ...
October 31, 2018 — Amgen announced a new Repatha cardiovascular outcomes study (FOURIER) analysis evaluating the effects ...
October 31, 2018 — Recent statin and medication advances have led some researchers to suggest surgical treatments for ...
October 17, 2018 — The U.S. Food and Drug Administration (FDA) has cleared an additional indication for rivaroxaban ...
October 11, 2018 — Novel results from the landmark EMPA-REG OUTCOME trial suggest that treatment with Jardiance ...